Qardio, Inc. is an American technology company founded by Marco Peluso and Rosario Iannella in early 2012. Based in San Francisco, California, Qardio specializes in heart health monitoring products aimed at improving cardiovascular health through innovative technology. Their product lineup includes QardioArm, QardioBase, QardioBase 2, QardioCore, and QardioMD, all of which are designed to provide users with clinically validated, award-winning devices for better health management. The company's mission is to empower individuals to take control of their heart health through smart, powerful, and user-friendly devices.
Notable figures associated with Qardio include CEO Mike Alvarez. The company has achieved significant milestones, including integration with the American Heart Association (AHA) and receiving multiple awards for their innovative products. Qardio's impact is evident in its contribution to the growing field of virtual care solutions, particularly in the realm of heart health. By leveraging AI and advanced technology, Qardio has positioned itself as a leader in the medical devices industry, making a substantial impact on how individuals monitor and manage their cardiovascular health.